Boc-1-氨基环丙基甲酸 | 88950-64-5

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - BOC-氨基酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: Boc-1-氨基环丙基甲酸
• 中文别名: Boc-1-氨基环丙烷羧酸；N-Boc-1-氨基环丙甲酸；1-(Boc-氨基)环丙基甲酸；1-Boc-氨基环丙烷羧酸；1-(叔丁氧羰基氨基)环丙烷甲酸
• 英文名称: 1-<(tert-butyloxy)carbonylamino>cyclopropane-1-carboxylic acid
• 英文别名: 1-(tert-butoxycarbonylamino)cyclopropanecarboxylic acid；1-((tert-butoxycarbonyl)amino)cyclopropane-1-carboxylic acid；1-(Boc-amino)cyclopropanecarboxylic acid；1-(N-Boc-amino)cyclopropane carboxylic acid；boc-1-aminocyclopropylcarboxylic acid；Boc-Acpc-OH；1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopropane-1-carboxylic acid
• CAS: 88950-64-5
• 化学式: C₉H₁₅NO₄
• mdl: MFCD00083257
• 分子量: 201.222
• InChiKey: DSKCOVBHIFAJRI-UHFFFAOYSA-N

物化性质

• 熔点：
  178 °C
• 沸点：
  347.6±21.0 °C(Predicted)
• 密度：
  1.21±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.777
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 安全说明：
  S22,S26,S36/37/39
• 危险类别码：
  R22,R36/37/38
• WGK Germany：
  3
• 海关编码：
  2924299090
• 危险品运输编号：
  NONH for all modes of transport
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Name:	1-[(tert-Butoxycarbonyl)amino]cyclopropanecarboxylic acid Material Safety Data Sheet
Synonym:	none know
CAS:	88950-64-5

Section 1 - Chemical Product MSDS Name:1-[(tert-Butoxycarbonyl)amino]cyclopropanecarboxylic acid Material Safety Data Sheet
Synonym:none know

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
88950-64-5	1-[(tert-Butoxycarbonyl)amino]cyclopro	97+%	unlisted

Hazard Symbols: XN
Risk Phrases: 22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions.

---

Section 7 - HANDLING and STORAGE
Handling:
Use with adequate ventilation. Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under nitrogen.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 88950-64-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: White
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 177 - 178 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H15NO4
Molecular Weight: 201.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Reacts explosively with a large number of compounds and elements.
Please refer to NFPA 's Fire Protection guide to Hazardous Materials for details. May explode on contact with oxidizing materials. Darkens on exposure to light. Produces acrid fumes in air.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 88950-64-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-[(tert-Butoxycarbonyl)amino]cyclopropanecarboxylic acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 88950-64-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 88950-64-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 88950-64-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

在5 L三口反应瓶中，加入201.7 g 1,1-环丙烷二甲酸单乙酯、351.3 g DPPA、167.6 g 三乙胺和2.4 L MeCO。室温搅拌反应3小时后，加热至90℃回流反应3小时。通过TLC监控反应完全程度，自然冷却至室温后，在50℃下旋蒸除去MeCO。随后使用(EA 400 mL + NaCO3 400 mL)×2进行萃取，分出有机相并减压浓缩去除t-BuOH和EA，最终得到Boc-1-氨基环丙基甲酸259.3 g，产率为88.7％。

反应信息

• 作为反应物：
  描述：

  Boc-1-氨基环丙基甲酸 在 盐酸羟胺 、 三乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 1-(Boc-amino)cyclopropane-1-carboxylic hydroxamate
  参考文献：
  名称：

  Ethylene biosynthesis. 12. Analog approach to the active site topography of the ethylene-forming enzyme. Novel hydroxamate inhibitors

  摘要：

  In order to understand both the substrate specificity and active site topography of the ethylene-forming enzyme (EFE), a number of analogs of its substrate, 1-aminocyclopropanecarboxylic acid, have been prepared and studied as inhibitors. Because of the dependence of EFE activity on iron, hydroxamic acids, a functional group known to bind iron tightly, derived from several small carboxylic/amino acids were studied along with the parent amino acids. The activity of these materials was assayed in vitro against the purified EFE from apple fruit. The varying potency of the amino acid hydroxamates suggests that they do not act simply by binding to iron and removing it from the enzyme. The order of their potency was consistent with the idea that binding reflects both metal chelation and hydrophobic interactions in the active site. The most potent inhibitor, ACC-hydroxamate, has about 1 mu M K-i.

  DOI：

  10.1021/jo00123a012
• 作为产物：
  描述：

  Boc-Ser.OpNB 在 甲醇 、 sodium hydroxide 、 N,N'-二环己基碳二亚胺 、 copper(l) chloride 作用下， 以 乙醚 、 氯仿 、 甲苯 为溶剂， 生成 Boc-1-氨基环丙基甲酸
  参考文献：
  名称：

  A new synthesis of racemic coronamic acid and other cyclopropyl amino acids

  摘要：

  DOI：

  10.1016/s0040-4039(00)94289-8
• 作为试剂：
  描述：

  5-氟-1H-吲哚-2-羧酸甲酯 在 copper diacetate 、 potassium carbonate 、 Boc-1-氨基环丙基甲酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 167.0h， 生成 1-amino-cyclopropanecarboxylic acid 4-[5-fluoro-2-(3-methyl-[1,2,4]oxadiazol-5-yl)-indol-1-yl]-benzylamide
  参考文献：
  名称：

  INDOLE DERIVATIVES

  摘要：

  本发明涉及式(I)的吲哚衍生物，其中R1-R6和X在权利要求中定义，并且其光学对映体或消旋体和/或盐是布雷金肽B1的选择性拮抗剂，用于制备这些化合物的方法，含有它们的药理学组合物以及它们在治疗或预防疼痛和炎症症状中的用途。

  公开号：

  US20130217702A1

文献信息

• [EN] CATHEPSIN INHIBITORS<br/>[FR] INHIBITEURS DE LA CATHEPSINE
  申请人：ACADEMISCH ZIEKENHUIS LEIDEN

  公开号：WO2019112426A1

  公开（公告）日：2019-06-13

  This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.

  这项发明涉及一种作为抑制剂有用的化合物，特别是作为Cathepsin K（CatK）的抑制剂，并涉及一种抑制蛋白酶活性的方法，包括给予根据该发明的化合物或配方的化合物。
• [EN] AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'AZÉTIDIN-3-YLMÉTHANOL EN TANT QUE MODULATEURS DU RÉCEPTEUR CCR6
  申请人：IDORSIA PHARMACEUTICALS LTD

  公开号：WO2021219849A1

  公开（公告）日：2021-11-04

  The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.

  本发明涉及式(I)化合物，其合成以及作为CCR6受体调节剂用于治疗或预防各种疾病、状况或障碍。
• Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
  申请人：Georgetown University

  公开号：US07202279B1

  公开（公告）日：2007-04-10

  The present invention provides 4-substituted-2-azetidinone compounds, bicyclic 2-5-diketopiperazine compounds, and pharmaceutical compositions thereof that are potent, safe and effective neuroprotective agents. Due to their strong central nervous system (CNS) activity, the compounds can be used to enhance memory and to treat a variety of neurological disorders. The compounds are particularly useful for treating neurological disorders caused by, or associated with, CNS trauma.

  本发明提供了4-取代-2-氮杂环己酮化合物、双环2-5-二酮哌嗪化合物及其药物组合物，它们是有效、安全且有效的神经保护剂。由于它们具有强大的中枢神经系统（CNS）活性，这些化合物可用于增强记忆力并治疗各种神经系统疾病。这些化合物特别适用于治疗由中枢神经系统创伤引起或与之相关的神经系统疾病。
• HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS
  申请人：CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD.

  公开号：US20170253614A1

  公开（公告）日：2017-09-07

  A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.

  一系列丙型肝炎病毒（HCV）抑制剂及其组合物，以及在制备用于治疗慢性HCV感染的药物时的应用。特别是一系列用作NS5A抑制剂的化合物，以及在药物制剂中的组合物和用途。
• [EN] DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES<br/>[FR] DÉRIVÉS D'AMIDES D'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-A]IMIDAZOLE-3-CARBOXYLIQUE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2010141273A1

  公开（公告）日：2010-12-09

  Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.

  6,7-二氢-5H-咪唑[1,2-a]咪唑-3-羧酸酰胺的衍生物对CAMs和白细胞整合素的相互作用具有良好的抑制作用，因此在炎症性疾病的治疗中很有用。

表征谱图